TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601
Published November 29, 2017 · Recall initiated: September 11, 2017
Summary
FDA records drug Class II recall D-0083-2018, published November 29, 2017 and initiated September 11, 2017. Recalling firm: United Therapeutics Corp.; Status: Terminated; Reported quantity: 12 devices; Lot: Lot #: 2101152; Exp. 12/11/2017 Lot #: 2101195; Exp. 04/26/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- United Therapeutics Corp.
- Distributor
- PA
- Lot
- Lot #: 2101152; Exp. 12/11/2017 Lot #: 2101195; Exp. 04/26/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANo. 1 Faiza Beauty Cream Manufactured by: Poonia Brothers (Pak), Gujranwala, Distributed by Shata TradersNovember 29, 2017
- FDALorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield,November 29, 2017
- FDAHARVEST(R) TERUMOBCT, BMAC2-120-01Bone Marrow Procedure Pack, REF 51423, Rx Only, STERILE EONovember 22, 2017
- FDAHARVEST(R) TERUMOBCT, BMAC-30-07 Bone Marrow Procedure Pack, Private Practice / Clinical Use Only, REF 51416,November 22, 2017
- FDAROSA Surgical Device 2.5.8. It is intended to be used in the operating room for the spatial positioning andNovember 22, 2017
- FDATyvaso (treprostinil) Inhalation Solution, Treprostinil 1.74 mg/2.9 mL, Four 2.9 mL Ampules, For OralJuly 16, 2014
Questions about this recall
Was TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601 recalled?
Yes. FDA published recall D-0083-2018 on November 29, 2017. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · Letter